R, G., BS, S., & KH, R. (2026). CRISPRi-mediated in vivo gene silencing: A tool for prioritizing drug targets in Mycobacterium abscessus. Antimicrobial agents and chemotherapy, 70(6), e0188925. https://doi.org/10.1128/aac.01889-25
Chicago Style (17th ed.) CitationR, Gupta, Simcox BS, and Rohde KH. "CRISPRi-mediated in Vivo Gene Silencing: A Tool for Prioritizing Drug Targets in Mycobacterium Abscessus." Antimicrobial Agents and Chemotherapy 70, no. 6 (2026): e0188925. https://doi.org/10.1128/aac.01889-25.
MLA (9th ed.) CitationR, Gupta, et al. "CRISPRi-mediated in Vivo Gene Silencing: A Tool for Prioritizing Drug Targets in Mycobacterium Abscessus." Antimicrobial Agents and Chemotherapy, vol. 70, no. 6, 2026, p. e0188925, https://doi.org/10.1128/aac.01889-25.